New & Noteworthy

April 2020

IV Compounding Service

Omnicell, Inc

Omnicell announces the expansion of its IV compounding service, an alternative to outsourcing. The service comprises updated technology, clinical expertise, operational support, and workflow/analytics to address challenges in sterile compounding. To enhance the service, Omnicell has added expert pharmacist consultants, best practice operating models, and a library of scientific data, including cGMP stability studies. These additions aim to streamline adoption and optimize performance, facilitate better production planning and staffing, establish beyond-use-dating programs, and increase financial return to customers.

Omnicell

Request More Information

Current Issue